- Previous Close
486.45 - Open
477.35 - Bid 454.55 x --
- Ask 455.35 x --
- Day's Range
452.35 - 496.50 - 52 Week Range
270.05 - 499.60 - Volume
5,904 - Avg. Volume
9,516 - Market Cap (intraday)
12.167B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
60.93 - EPS (TTM)
7.54 - Earnings Date Oct 23, 2024
- Forward Dividend & Yield 5.00 (1.03%)
- Ex-Dividend Date Sep 6, 2024
- 1y Target Est
--
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
www.jagsonpal.com1,025
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: JAGSNPHARM.BO
View MorePerformance Overview: JAGSNPHARM.BO
Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JAGSNPHARM.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JAGSNPHARM.BO
View MoreValuation Measures
Market Cap
12.88B
Enterprise Value
11.49B
Trailing P/E
64.52
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.22
Price/Book (mrq)
6.87
Enterprise Value/Revenue
5.51
Enterprise Value/EBITDA
35.57
Financial Highlights
Profitability and Income Statement
Profit Margin
9.67%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.1B
Net Income Avi to Common (ttm)
203.13M
Diluted EPS (ttm)
7.54
Balance Sheet and Cash Flow
Total Cash (mrq)
1.48B
Total Debt/Equity (mrq)
4.77%
Levered Free Cash Flow (ttm)
--